Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-038431
Filing Date
2025-08-06
Accepted
2025-08-06 17:31:25
Documents
67
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vir-20250630.htm   iXBRL 10-Q 1266218
2 EX-31.1 a20250630-q210qex311.htm EX-31.1 10763
3 EX-31.2 a20250630-q210qex312.htm EX-31.2 10991
4 EX-32.1 a20250630-q210qex321.htm EX-32.1 8207
  Complete submission text file 0001628280-25-038431.txt   6151943

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vir-20250630.xsd EX-101.SCH 46173
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vir-20250630_cal.xml EX-101.CAL 75472
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vir-20250630_def.xml EX-101.DEF 199660
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vir-20250630_lab.xml EX-101.LAB 570134
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vir-20250630_pre.xml EX-101.PRE 386402
70 EXTRACTED XBRL INSTANCE DOCUMENT vir-20250630_htm.xml XML 698445
Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39083 | Film No.: 251190794
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)